Literature DB >> 12515721

Clonal expansion of CD8+ BV8 T lymphocytes in bone marrow characterizes thymoma-associated B lymphopenia.

Anna Maria Masci1, Giovannella Palmieri, Laura Vitiello, Liliana Montella, Francesco Perna, Paola Orlandi, Gianfranco Abbate, Serafino Zappacosta, Raffaele De Palma, Luigi Racioppi.   

Abstract

A subgroup of thymoma patients is affected by severe immunodeficiency clinically resembling an HIV infection (Good syndrome). These individuals are characterized by B lymphopenia with B-lymphopoiesis deficiency. To investigate the pathogenesis of this unique condition, we studied the T-cell repertoire in blood and bone marrow samples by heterogeneity length analysis of CDR3 beta variable regions of the T-cell receptor (spectratyping). While no alterations were found in the peripheral blood, we detected an oligoclonal population of beta variable 8 (BV8) CD8(+) T cells in 5 of 5 bone marrow samples. No lymphocyte expansions were found in the bone marrow of 2 thymoma patients with normal B-cell counts, 2 healthy donors, and 3 patients with diseases unrelated to thymoma. These data suggest that an immune response toward an unknown antigen is taking place in the bone marrow of B-lymphopenic thymoma patients. We propose that BV8 CD8(+) T cells may play a role in the pathogenesis of this immunodeficiency syndrome.

Entities:  

Mesh:

Year:  2002        PMID: 12515721     DOI: 10.1182/blood-2002-08-2638

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Myelodysplasia and Good syndrome. A case report.

Authors:  M Di Renzo; A L Pasqui; L Voltolini; G Gotti; G Pompella; A Auteri
Journal:  Clin Exp Med       Date:  2008-09-13       Impact factor: 3.984

2.  Paraneoplastic syndromes in thymoma: an immunological perspective.

Authors:  Robert P Nelson; Robert M Pascuzzi
Journal:  Curr Treat Options Oncol       Date:  2009-02-06

Review 3.  Signs heralding appearance of thymomas after extended thymectomy for myasthenia gravis.

Authors:  Ernestina Santos; Ana Martins Silva; Philipp Stroebel; Antonio Marinho; Nick Willcox; Guilherme Goncalves; Carlos Lopes; Alexander Marx; Maria Isabel Leite
Journal:  Neurol Clin Pract       Date:  2019-02

4.  Prolonged severe immunodeficiency following thymectomy and radiation: a case report.

Authors:  Johanna Lee Wickemeyer; Sudhir Sekhsaria
Journal:  J Med Case Rep       Date:  2014-12-21

5.  Clinical and laboratory features of seventy-eight UK patients with Good's syndrome (thymoma and hypogammaglobulinaemia).

Authors:  M Zaman; A Huissoon; M Buckland; S Patel; H Alachkar; J D Edgar; M Thomas; G Arumugakani; H Baxendale; S Burns; A P Williams; S Jolles; R Herriot; R B Sargur; P D Arkwright
Journal:  Clin Exp Immunol       Date:  2018-10-21       Impact factor: 4.330

6.  Deciphering the biology of thymic epithelial tumors.

Authors:  Arun Rajan; Chen Zhao
Journal:  Mediastinum       Date:  2019-09-17

Review 7.  Molecular pathology of thymomas: implications for diagnosis and therapy.

Authors:  Alexander Marx; Djeda Belharazem; De-Hyung Lee; Zoran V Popovic; Christoph Reißfelder; Berthold Schalke; Sebastian Schölch; Philipp Ströbel; Cleo-Aron Weis; Yosuke Yamada
Journal:  Virchows Arch       Date:  2021-03-05       Impact factor: 4.064

Review 8.  Good's Syndrome: Time to Move on From Reviewing the Past.

Authors:  Aunonna Kabir; Reza Alizadehfar; Christos M Tsoukas
Journal:  Front Immunol       Date:  2022-01-12       Impact factor: 7.561

Review 9.  The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?

Authors:  Liliana Montella; Margaret Ottaviano; Rocco Morra; Erica Pietroluongo; Pietro De Placido; Marianna Tortora; Chiara Sorrentino; Gaetano Facchini; Sabino De Placido; Mario Giuliano; Giovannella Palmieri
Journal:  Cancers (Basel)       Date:  2022-02-02       Impact factor: 6.639

10.  Immunological signature of patients with thymic epithelial tumors and Good syndrome.

Authors:  Anna Maria Malfitano; Vittoria D'Esposito; Pietro De Placido; Marianna Tortora; Margaret Ottaviano; Erica Pietroluongo; Rocco Morra; Brigitta Mucci; Fabiana Napolitano; Liliana Montella; Mario Giuliano; Sabino De Placido; Daniela Terracciano; Giovannella Palmieri; Pietro Formisano
Journal:  Front Immunol       Date:  2022-08-18       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.